Restless legs syndrome (RLS) is a common neurological sleep disorder with a high global prevalence, yet it remains frequently underdiagnosed.As a result, a considerable proportion of patients fail to receive timely and adequate treatment.While pharmacological therapy represents a cornerstone of management, nonpharmacological interventions constitute an essential component for optimizing clinical outcomes.Behavioral approaches and other strategies beyond dopaminergic agonists or alpha-2-delta ligands have shown significant potential in improving sleep quality and, consequently, overall quality of life in affected individuals.This article provides a comprehensive review of these alternative approaches, focusing on their proposed mechanisms of action and outlining potential pathways for their clinical application.
Labra et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: